Zydus Lifesciences inks pact with PAI Partners, other shareholders to buy majority stake in Amplitude Surgical SA
Advertisement
Ahmedabad: Following the joint announcement of March 11, 2025, Zydus Lifesciences Limited and Amplitude Surgical SA have announced that Amplitude has conducted the mandatory information and consultation process with the works council of Amplitude SAS.
Consequently, Zydus has signed the share purchase agreement to acquire 75.4% of the share capital of Amplitude at a price of €6.25 per Amplitude share from PAI Partners, Olivier Jallabert and other managers of Amplitude, which together with the two share purchase agreements already signed on March 11, 2025 with two minority shareholders represent 85.6% of the share capital of Amplitude (the “Block Acquisition”).
As indicated in the joint announcement of March 11, 2025, the completion of the Block Acquisition remains subject to the usual closing conditions, including authorization from the French Minister of Economy as part of the control of foreign investments in France, the re-investment by Amplitude CEO Olivier Jallabert into the company, as well as the absence of qualified material adverse events.
Subject to the fulfilment of the closing conditions, Zydus will acquire 85.6% of the share capital of Amplitude. The closing of the Block Acquisition is now expected to be completed by Q3 2025.
After such completion, Zydus’ mandatory simplified tender offer would be filed with the Autorité des Marchés Financiers (“AMF”) and would be followed by a squeeze out if the conditions are met. The opening of the subsequent tender offer would then remain subject to the AMF’s clearance decision. In this respect and as announced on April 17, 2025, commitments to tender 4.7% of Amplitude’s share capital have been executed with other minority shareholders of Amplitude. As a consequence, and subject to the condition precedents hereabove, Zydus will be in a position to acquire more than 90 % of the capital and voting rights of Amplitude at the end of the tender offer, and therefore to implement a squeeze-out procedure.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.